DISSOLVABLE PHARMACEUTICAL IMPLANT
A pharmaceutical implant may include at least one pharmaceutical and at least one excipient. The at least one excipient may dissolve after implantation of the pharmaceutical implant in the body of the patient and release the pharmaceutical. The at least one excipient may be selected to provide a des...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
07.06.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A pharmaceutical implant may include at least one pharmaceutical and at least one excipient. The at least one excipient may dissolve after implantation of the pharmaceutical implant in the body of the patient and release the pharmaceutical. The at least one excipient may be selected to provide a desired release profile of the pharmaceutical. For example, the pharmaceutical implant may be configured to dissolve and release the pharmaceutical over a length of time between about one day and about 30 days. In some examples, the pharmaceutical implant may be implanted in the body of the patient proximate to an implantable medical device.
La présente invention concerne un implant pharmaceutique qui peut comprendre un médicament et au moins un excipient. Le ou les excipients peuvent se dissoudre après implantation de l'implant pharmaceutique dans le corps du patient et libérer le médicament. Le ou les excipients peuvent être sélectionnés pour procurer un profil de libération voulu dudit médicament. Par exemple, l'implant pharmaceutique peut être conçu pour se dissoudre et libérer le médicament pendant une période comprise entre environ un jour et environ 30 jours. Dans certains exemples, l'implant pharmaceutique peut être implanté dans le corps du patient à proximité d'un dispositif médical implantable. |
---|---|
AbstractList | A pharmaceutical implant may include at least one pharmaceutical and at least one excipient. The at least one excipient may dissolve after implantation of the pharmaceutical implant in the body of the patient and release the pharmaceutical. The at least one excipient may be selected to provide a desired release profile of the pharmaceutical. For example, the pharmaceutical implant may be configured to dissolve and release the pharmaceutical over a length of time between about one day and about 30 days. In some examples, the pharmaceutical implant may be implanted in the body of the patient proximate to an implantable medical device.
La présente invention concerne un implant pharmaceutique qui peut comprendre un médicament et au moins un excipient. Le ou les excipients peuvent se dissoudre après implantation de l'implant pharmaceutique dans le corps du patient et libérer le médicament. Le ou les excipients peuvent être sélectionnés pour procurer un profil de libération voulu dudit médicament. Par exemple, l'implant pharmaceutique peut être conçu pour se dissoudre et libérer le médicament pendant une période comprise entre environ un jour et environ 30 jours. Dans certains exemples, l'implant pharmaceutique peut être implanté dans le corps du patient à proximité d'un dispositif médical implantable. |
Author | GALLAGHER, GENEVIEVE, L CHAFFIN, KIMBERLY, A YANG, ZHONGPING, C |
Author_xml | – fullname: CHAFFIN, KIMBERLY, A – fullname: GALLAGHER, GENEVIEVE, L – fullname: YANG, ZHONGPING, C |
BookMark | eNrjYmDJy89L5WRQcvEMDvb3CXN08nFVCPBwDPJ1dHYNDfF0dvRR8PQN8HH0C-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGhkYG5qZGlmaOhsbEqQIAuwYlSw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | IMPLANT PHARMACEUTIQUE SOLUBLE |
ExternalDocumentID | WO2012075296A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2012075296A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:13:40 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2012075296A13 |
Notes | Application Number: WO2011US62902 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120607&DB=EPODOC&CC=WO&NR=2012075296A1 |
ParticipantIDs | epo_espacenet_WO2012075296A1 |
PublicationCentury | 2000 |
PublicationDate | 20120607 |
PublicationDateYYYYMMDD | 2012-06-07 |
PublicationDate_xml | – month: 06 year: 2012 text: 20120607 day: 07 |
PublicationDecade | 2010 |
PublicationYear | 2012 |
RelatedCompanies | GALLAGHER, GENEVIEVE, L CHAFFIN, KIMBERLY, A YANG, ZHONGPING, C MEDTRONIC, INC |
RelatedCompanies_xml | – name: CHAFFIN, KIMBERLY, A – name: YANG, ZHONGPING, C – name: GALLAGHER, GENEVIEVE, L – name: MEDTRONIC, INC |
Score | 2.8562477 |
Snippet | A pharmaceutical implant may include at least one pharmaceutical and at least one excipient. The at least one excipient may dissolve after implantation of the... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | DISSOLVABLE PHARMACEUTICAL IMPLANT |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120607&DB=EPODOC&locale=&CC=WO&NR=2012075296A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbFaJajkFkzSbTY9FMmTVPKiTWtvJY8NCFKLjfj3nY2p9tTb7g7MPmBm9tt5LMAjRTOkZ3omlf2CSUTTVCnlkQAKGeT6kOaMZvy9Iwg1b0ZeFoNFC963uTB1ndDvujgiSlSO8l7V-nr9_4hl17GVm6fsDYc-nt1kZIsNOlZUWZOpaJsjJ47syBItC3GbGE5-aZQ7GQ3ESgf8Is0r7Ttzk-elrHeNinsKhzHyW1Vn0GKrDhxb27_XOnAUNC5vbDbStzmHe3s8nUb-3DB9R4g9YxIYljNLeEUDYRzEvhEmF_DgOonlSTjZ8m9vy9dod2X9S2gj6mdXICglqjCmcQA5JCmT01wtiUKUgshFiQqqC719nK73k2_ghHfrmCfag3b1-cVu0bpW2V19KD8OGnh9 |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjalDJLZik22x6KJImKanmRZvW3kKSbkCQWmzEv-_s2mpPvS07MPuAmeGbnfkW4IFiGDJzM1fK9pwpxDB0JeOVABrpFGaXFozmPN8RhIY3Ic-zzqwG75teGMET-i3IEdGiCrT3Svjr5X8SyxG1lavH_A2nPp4GSc-R1-hY01VDpbLT77lx5ES2bNuI2-Rw9Cuj_JHRQqy0RxEUcqZ9d9rnfSnL7aAyOIL9GPUtqmOosUUTGvbm77UmHATrJ28crq1vdQJ3znA8jvyp1fddKfasUWDZ7iThjAbSMIh9K0xO4X7gJran4GLp39nS12h7Z-0zqCPqZ-cgaSW6MGZwANklGVOzQi-JRrQ5UeclOqgLaO3SdLlbfAsNLwn81B-GL1dwyEWi_om2oF59frFrjLRVfiMu6AfWLXto |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DISSOLVABLE+PHARMACEUTICAL+IMPLANT&rft.inventor=CHAFFIN%2C+KIMBERLY%2C+A&rft.inventor=GALLAGHER%2C+GENEVIEVE%2C+L&rft.inventor=YANG%2C+ZHONGPING%2C+C&rft.date=2012-06-07&rft.externalDBID=A1&rft.externalDocID=WO2012075296A1 |